Vue normale Vue MARC vue ISBD

Efficacy of capecitabine and temozolomide finally demonstrated in advanced pancreatic neuroendocrine tumors, and predictable by the MGMT biomarker

d’Engremont, Christelle

Efficacy of capecitabine and temozolomide finally demonstrated in advanced pancreatic neuroendocrine tumors, and predictable by the MGMT biomarker - 2023.

79

Imprimer
Ajouter à mon panier (Supprimer)
Rapporter un problème
Enregistrer la notice
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
Plus de recherches

Chercher ce titre dans :
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Efficacy of capecitabine and temozolomide finally demonstrated in advanced pancreatic neuroendocrine tumors, and predictable by the MGMT biomarker

PLUDOC

Adresse

Liens utiles

Efficacy of capecitabine and temozolomide finally demonstrated in advanced pancreatic neuroendocrine tumors, and predictable by the MGMT biomarker

PLUDOC

Adresse

Réseaux sociaux

Liens utiles